Intrahepatic implantation of tumor cells v1

2021 ◽  
Author(s):  
Shubhangi Agarwal ◽  
Robert Bok ◽  
donna.peehl not provided ◽  
Renuka Sriram
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient ◽  
Tumor Cell Line ◽  
Small Cell ◽  
Response To Therapy ◽  
Tumor Characteristics ◽  
Patient Derived Xenograft ◽  
Neuroendocrine Prostate Cancer

This protocol describes the steps required for successful implantation of small cell neuroendocrine prostate cancer patient-derived xenograft (PDX) cells in the liver. Liver is one of the most common sites for development of metastatic prostate cancer and its study is important for evaluating the tumor characteristics and response to therapy. This protocol can be used for implantation of any tumor cell line in the liver.

Intratibial implantation of tumor cells  v1

2021 ◽  
Author(s):  
Shubhangi Agarwal ◽  
donna.peehl not provided ◽  
Renuka Sriram
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient ◽  
Tumor Cell Line ◽  
Small Cell ◽  
Response To Therapy ◽  
Tumor Characteristics ◽  
Patient Derived Xenograft ◽  
Neuroendocrine Prostate Cancer

This protocol describes the steps required for the successful implantation of small cell neuroendocrine prostate cancer patient-derived xenograft (PDX) cells in the bone. Bone is one of the most common sites for the development of metastatic prostate cancer and its study is important for evaluating the tumor characteristics and response to therapy. This protocol can be used for the implantation of any tumor cell line in the bone.

Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [18F]DCFPyL PET Imaging

2021 ◽  
Author(s):  
Jyoti Roy ◽  
Margaret E. White ◽  
Falguni Basuli ◽  
Ana Christina L. Opina ◽  
Karen Wong ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Mouse Models ◽  
Pet Imaging ◽  
Prostate Cancer Patient ◽  
Patient Derived Xenograft

scholarly journals Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity

2020 ◽  
Vol 10 ◽  
Author(s):  
Federico La Manna ◽  
Marta De Menna ◽  
Nikhil Patel ◽  
Sofia Karkampouna ◽  
Maria De Filippo ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Tumor Heterogeneity ◽  
Mtor Inhibitor ◽  
Prostate Cancer Patient ◽  
Xenograft Growth ◽  
Patient Derived Xenograft

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient

Onkologie ◽  
2010 ◽  
Vol 33 (1-2) ◽  
pp. 57-59 ◽  
Author(s):  
Joan M. Gasent Blesa ◽  
Vicente Alberola Candel
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient

scholarly journals Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

10.3791/53182 ◽  
2015 ◽  
Author(s):  
Estrelania S. Williams ◽  
Veronica Rodriquez-Bravo ◽  
Uma Chippada-Venkata ◽  
Janis De Ia Iglesia-Vicente ◽  
Yixuan Gong ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Prostate Cancer Patient ◽  
Patient Derived Xenograft ◽  
Xenograft Models

scholarly journals Stafnea�(TM)s bone defect in a metastatic prostate cancer patient: A diagnostic conundrum

2017 ◽  
pp. 0-0
Author(s):  
WG da Silva ◽  
AT Kemp ◽  
AR dos Santos-Silva ◽  
MPE Diz ◽  
TB Brandão
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Bone Defect ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient
Sign in / Sign up

Export Citation Format

Share Document